TATA Health International Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for TATA Health International Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Specialty Retail earnings growth | 22.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Pinning Down TATA Health International Holdings Limited's (HKG:1255) P/S Is Difficult Right Now
Mar 01
Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?
Nov 02TATA Health International Holdings Limited's (HKG:1255) Business Is Trailing The Industry But Its Shares Aren't
Aug 04Does TATA Health International Holdings (HKG:1255) Have A Healthy Balance Sheet?
Apr 09Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?
Sep 16Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?
Nov 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TATA Health International Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 185 | -23 | -1 | -2 | N/A |
| 3/31/2023 | 165 | -7 | 5 | 6 | N/A |
| 12/31/2022 | 145 | 10 | 12 | 13 | N/A |
| 9/30/2022 | 148 | -2 | 7 | 5 | N/A |
| 6/30/2022 | 151 | -14 | 2 | -3 | N/A |
| 3/31/2022 | 156 | -37 | -2 | -4 | N/A |
| 12/31/2021 | 161 | -61 | -6 | -5 | N/A |
| 9/30/2021 | 155 | -77 | -12 | -7 | N/A |
| 6/30/2021 | 149 | -94 | -17 | -9 | N/A |
| 3/31/2021 | 152 | -123 | -10 | -4 | N/A |
| 12/31/2020 | 155 | -152 | -3 | 0 | N/A |
| 9/30/2020 | 192 | -147 | -6 | -3 | N/A |
| 6/30/2020 | 229 | -143 | -10 | -5 | N/A |
| 3/31/2020 | 285 | -102 | 1 | 5 | N/A |
| 12/31/2019 | 342 | -61 | 11 | 16 | N/A |
| 9/30/2019 | 357 | -33 | 3 | 7 | N/A |
| 6/30/2019 | 373 | -4 | -6 | -3 | N/A |
| 3/31/2019 | 366 | -3 | 5 | 7 | N/A |
| 12/31/2018 | 358 | -2 | 16 | 18 | N/A |
| 9/30/2018 | 387 | -12 | N/A | N/A | N/A |
| 6/30/2018 | 417 | -23 | 86 | 87 | N/A |
| 3/31/2018 | 450 | -33 | 76 | 78 | N/A |
| 12/31/2017 | 484 | -43 | 66 | 69 | N/A |
| 9/30/2017 | 503 | -40 | N/A | N/A | N/A |
| 6/30/2017 | 523 | -36 | 23 | 27 | N/A |
| 3/31/2017 | 543 | -35 | N/A | 18 | N/A |
| 12/31/2016 | 562 | -34 | N/A | 9 | N/A |
| 9/30/2016 | 568 | -33 | N/A | -16 | N/A |
| 6/30/2016 | 574 | -31 | N/A | -41 | N/A |
| 3/31/2016 | 568 | -24 | N/A | -65 | N/A |
| 12/31/2015 | 561 | -16 | N/A | -89 | N/A |
| 9/30/2015 | 565 | -11 | N/A | -77 | N/A |
| 6/30/2015 | 568 | -6 | N/A | -65 | N/A |
| 3/31/2015 | 579 | 1 | N/A | -41 | N/A |
| 12/31/2014 | 591 | 9 | N/A | -16 | N/A |
| 9/30/2014 | 589 | 14 | N/A | -15 | N/A |
| 6/30/2014 | 587 | 18 | N/A | -14 | N/A |
| 3/31/2014 | 568 | 17 | N/A | -12 | N/A |
| 12/31/2013 | 550 | 17 | N/A | -9 | N/A |
| 9/30/2013 | 536 | 21 | N/A | -7 | N/A |
| 6/30/2013 | 523 | 25 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1255's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 1255's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1255's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1255's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1255's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1255's Return on Equity is forecast to be high in 3 years time